-
NASH Sympathy Plays On Tobira Therapeutics Deal
Tuesday, September 20, 2016 - 2:43pm | 499Read More...Shares of Tobira Therapeutics Inc (NASDAQ: TBRA) soared higher by more than 700 percent on Tuesday after the company was acquired by Allergan plc Ordinary Shares (NYSE: AGN). The massive premium Allergan is paying in Tobira's stock price has many investors questioning if any of Tobira's peers are...
-
Here's Why Conatus Pharmaceuticals' Stock Surged 23%
Wednesday, February 3, 2016 - 1:26pm | 249Read More...Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT), a nano-cap biotechnology company focused on the development and commercialization of medicines to treat liver disease, surged higher by more than 22 percent on Wednesday. Conatus Pharmaceuticals announced earlier in the day that the U.S....
-
On Wall Street, Questions Remain For Conatus Pharma
Friday, September 25, 2015 - 9:05am | 588Read More...Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT) were higher by nearly 5 percent on Thursday, although shares initially surged higher by more than 30 percent following the announcement on Wednesday. Conatus announced results from its Phase II study of emricasan in 22 Portal Hypertension...
